DEVIN BRECHEEN: Open Payments
NPI 1447534854 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,608 in 76 payments from 22 companies in 2025. Trend: 2023 $2,385 · 2024 $618 · 2025 $1,608
Food & beverage: $1,509Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $243 |
| Janssen Biotech, Inc. | 8 | $239 |
| ABBVIE INC. | 9 | $162 |
| Incyte Corporation | 8 | $151 |
| PFIZER INC. | 4 | $94 |
| Eisai Inc. | 5 | $90 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Merck Sharp & Dohme LLC | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| GlaxoSmithKline, LLC. | 3 | $55 |
Products named: EPKINLY, DARZALEX, Lenvima, MONJUVI, LIBTAYO, IMJUDO, KEYTRUDA, ENHERTU.
Industry payments across TX — which companies pay providers there.
